FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:779 September 10, 1998 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Second edition. By Daniel B. Kopans. 875 pp., illustrated. Philadelphia, Lippincott-Raven, 1998. $125. ISBN 0-397-51302-X.

That screening mammography substantially reduces mortality from breast cancer is a major medical accomplishment of our time and one with potential remaining to be fulfilled. During its development, mammography has taught us much about the biology of breast cancer, the validation and quantification of both the benefit and the potential harm of screening, the relation of technical and interpretive quality to outcomes, the need for scientific assessment of new imaging methods that might supplement or replace mammography, and the uncertainties of mammographic interpretation. In each of these areas, the history of mammography provides invaluable lessons that are applicable to the . . . [Full Text of this Article]

This article has been cited by other articles:

• Apple, F. S., Murakami, M. M., Pearce, L. A., Herzog, C. A. (2002). Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease. Circulation 106: 2941-2945 [Abstract] [Full Text]